Infant Formula Supplemental Appropriations Act, 2022 2022-05-18 Passed House Infant Formula Supplemental Appropriations Act, 2022

This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States.

Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by taking the steps that are necessary to prevent fraudulent products from entering the U.S. market.

]]> 2022-05-17 Introduced in House Infant Formula Supplemental Appropriations Act, 2022

This bill provides $28 million in emergency supplemental appropriations to address the shortage of infant formula in the United States.

Specifically, the bill provides appropriations for the Food and Drug Administration (FDA) to (1) address the current shortage of FDA-regulated infant formula and certain medical foods in the United States; and (2) prevent future shortages, including by taking the steps that are necessary to prevent fraudulent products from entering the U.S. market.

]]> text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.